Previous Close -
Market Cap 956.04M
PE Ratio -11.03
Volume (Avg. Vol.)
Days Range 4.08 - 4.08
52-Week Range 0.32 - 6.95
Dividend & Yield N/A (N/A)
TRXC Stock Predictions, Articles, and Transenterix Inc News
- From InvestorPlace
- From the Web
Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.
Whether you’re looking to invest in TRXC stock or its successor, Asensus Surgical, you’ll need something to handle the volatility.
Asensus and TRXC stock has gotten a $1 billion market cap on introducing Senhance, a robotic surgery system for abdominal surgery. Knowing whether it will succeed will take time.
Shares of TRXC stock are rising on Wednesday after the firm received general surgery clearance from the FDA for its Senhance Surgical System.
TRXC stock is a better option than many “meme” stocks that retail investors have bid higher. It’s a reminder that a little bit of homework can go a long way.
TRXC stock has pulled off a nice rally. But the company’s systems could take some time to get traction.
TRXC stock could become the next Intuitive Surgical. The company is funded, and has to simply develop its business now.
TransEnterix announced a company renaming amid a broad selloff that had TRXC stock down 16.6% in trading today.
What did the stock market do today? Here is what you need to know to profit after a stunning turnaround in stocks.
TRXC stock has struggled badly since its 2014 IPO. A trader-driven rally is unlikely to change the concerning long-term trend.
As TRXC stock takes a breather amid a sustained uptrend, investors should consider owning shares of this medical robotics innovator.
With its ultra-low price point and the relevant business of minimally invasive surgeries, TRXC stock has garnered much attention. Still, prospective buyers should look at the broader context before diving in.
TRXC stock has potential to become the next Intuitive Surgical with its Senhance platform opening up a multi-billion dollar revenue stream
TransEnterix is facing competition from a number of much larger companies, while its revenue is quite low. Investors should take profits on TRXC stock.
So, after contrasting the opportunities and risks with TRXC stock, whats the play? It may be interesting at lower prices. But, for now, hold off buying.
TransEnterix is currently trading above $5. But does TRXC stock have what it takes to be the next Intuitive Surgical?
TransEnterix stock is up in trading today after a pair of big stock sales and ahead of its Feb. 23 Investor Day.
Surgical robotics is a fascinating market niche with huge potential, and you can capitalize on its expansion with a position in TRXC stock.
Insider trading can give outside investors valuable clues and insights. This includes both insider buying and selling.
TransEnterix (TRXC) is seeing shares of TRXC stock soar higher on Tuesday following an update concerning its Intelligent Surgical Unit.